Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation.
Sakai R, Kanamori H, Motohashi K, Yamamoto W, Matsuura S, Fujita A, Ohshima R, Kuwabara H, Tanaka M, Fujita H, Maruta A, Ishigatsubo Y, Fujisawa S. Sakai R, et al. Among authors: ohshima r. Biol Blood Marrow Transplant. 2011 Sep;17(9):1389-94. doi: 10.1016/j.bbmt.2011.01.014. Epub 2011 Feb 4. Biol Blood Marrow Transplant. 2011. PMID: 21296175 Free article.
Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.
Tachibana T, Tanaka M, Takasaki H, Numata A, Ito S, Watanabe R, Hyo R, Ohshima R, Hagihara M, Sakai R, Fujisawa S, Tomita N, Fujita H, Maruta A, Ishigatsubo Y, Kanamori H. Tachibana T, et al. Among authors: ohshima r. Int J Hematol. 2011 Mar;93(3):368-374. doi: 10.1007/s12185-011-0784-0. Epub 2011 Feb 18. Int J Hematol. 2011. PMID: 21331523
Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk.
Tachibana T, Tanaka M, Numata A, Takasaki H, Ito S, Ohshima R, Hagihara M, Yamazaki E, Tomita N, Fujimaki K, Taguchi J, Sakai R, Fujita H, Fujisawa S, Maruta A, Ishigatsubo Y, Kanamori H. Tachibana T, et al. Among authors: ohshima r. Leuk Lymphoma. 2012 Mar;53(3):456-61. doi: 10.3109/10428194.2011.619607. Epub 2011 Oct 24. Leuk Lymphoma. 2012. PMID: 21883028
Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.
Motohashi K, Suzuki T, Kishimoto K, Numata A, Nakajima Y, Tachibana T, Ohshima R, Kuwabara H, Tanaka M, Tomita N, Ishigatsubo Y, Fujisawa S. Motohashi K, et al. Among authors: ohshima r. Int J Hematol. 2013 Aug;98(2):258-60. doi: 10.1007/s12185-013-1387-8. Epub 2013 Jun 26. Int J Hematol. 2013. PMID: 23801427
[ABVD chemotherapy for Hodgkin lymphoma at a single institute].
Ohshima R, Motomura S, Hashimoto C, Miyazaki T, Ito S, Takasaki H, Hyo R, Koharazawa H, Takemura S, Yamazaki E, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Kanamori H, Ishigatsubo Y. Ohshima R, et al. Rinsho Ketsueki. 2010 Dec;51(12):1756-61. Rinsho Ketsueki. 2010. PMID: 21258185 Japanese.
46 results